Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Endometrial Neoplasms × olaparib × Clear all

Status

Sponsor Class

Study Type

Interventional 16 Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Neoplasms 2 Relapsed Ovarian Cancers Patients 1 Kenny-Caffey syndrome, Type 1 1 Hyperglycemia 1 Endometrial Neoplasms 1 Breast Neoplasms 1 Breast Cancer Organoids 1

Interventions

Surveys and Questionnaires 14 Blood Specimen Collection 7 Observation 5 Surgical Procedures, Operative 4 Hysteroscopy 4 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Hysterectomy 3 Ultrasonography 2 Specimen Handling 2 Reverse Transcriptase Polymerase Chain Reaction 2 Psychiatric Rehabilitation 2 Laparoscopy 2 Immunohistochemistry 2 Data Collection 2 trastuzumab deruxtecan 1 semaglutide 1 sarcolipin 1 rubitecan 1 olaparib 1 dostarlimab 1 X-Rays 1 Vaginal Smears 1 Tissue Banks 1 Therapeutics 1 Sutures 1 Sentinel Lymph Node Biopsy 1 Ropivacaine 1 Restraint, Physical 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02506816 2020-11-30

Polen

MedSIR

36 enrolled 10 charts

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡